Literature DB >> 8226969

Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1.

M Mali1, K Elenius, H M Miettinen, M Jalkanen.   

Abstract

The expression of syndecan-1, the prototype member of the cell surface proteoglycan family, follows morphogenetic rather than histological boundaries during organ formation. As a heparan sulfate-containing cell surface molecule, syndecan-1 can simultaneously bind various components of the extracellular matrix and members of the heparin-binding growth factors. Indeed, syndecan-1 may act as a co-receptor for basic fibroblast growth factor (bFGF) (Salmivirta, M., Heino, J., and Jalkanen, M. (1992) J. Biol. Chem. 267, 17606-17610), allowing the growth factor to bind the tyrosine kinase bFGF receptor. We have studied the role of syndecan-1 in growth factor response by growing 3T3 cells transfected with syndecan-1 in the presence of bFGF. The enhanced expression of syndecan-1 caused down-regulation of bFGF-induced cell proliferation and, at the same time, enhancement of cell matrix interactions. Thus, the induced expression of the heparan sulfate co-receptor (syndecan-1) may provide a mechanism to restrict FGF action and modulate cell-matrix interactions to maintain co-ordinated growth of cells during organ formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226969

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer.

Authors:  Yunping Hu; Haiguo Sun; Rick T Owens; Zhennan Gu; Jansheng Wu; Yong Q Chen; Joseph T O'Flaherty; Iris J Edwards
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  Activation of an enhancer on the syndecan-1 gene is restricted to fibroblast growth factor family members in mesenchymal cells.

Authors:  P Jaakkola; T Vihinen; A Määttä; M Jalkanen
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

3.  Expression of cytokeratin 8, vimentin, syndecan-1 and Ki-67 during human tooth development.

Authors:  D Kero; D Kalibovic Govorko; K Vukojevic; M Cubela; V Soljic; M Saraga-Babic
Journal:  J Mol Histol       Date:  2014-08-15       Impact factor: 2.611

4.  Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan.

Authors:  C Marchisone; F Del Grosso; L Masiello; M Prat; L Santi; D M Noonan
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  Heparan sulfate proteoglycans mediate factor XIIa binding to the cell surface.

Authors:  Lukasz Wujak; Miroslava Didiasova; Dariusz Zakrzewicz; Helena Frey; Liliana Schaefer; Malgorzata Wygrecka
Journal:  J Biol Chem       Date:  2015-01-14       Impact factor: 5.157

Review 6.  Proteoglycans in prostate cancer.

Authors:  Iris J Edwards
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

7.  Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.

Authors:  Valentina Masola; Giovanni Gambaro; Elena Tibaldi; Anna Maria Brunati; Alessandra Gastaldello; Angela D'Angelo; Maurizio Onisto; Antonio Lupo
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

Review 8.  Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland.

Authors:  M Delehedde; M Lyon; N Sergeant; H Rahmoune; D G Fernig
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

Review 9.  Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules.

Authors:  M Salmivirta; M Jalkanen
Journal:  Experientia       Date:  1995-09-29

10.  Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains.

Authors:  F Zong; E Fthenou; J Castro; B Péterfia; I Kovalszky; L Szilák; G Tzanakakis; K Dobra
Journal:  Cell Prolif       Date:  2009-10-13       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.